Skeletal muscle mass and quality: Evolution of modern measurement concepts in the context of sarcopenia

Proceedings of the Nutrition Society

Volumn 74, Issue 4, 2015, Pages 355-366

  Heymsfield, Steven B ^a   Gonzalez, M Cristina ^b   Lu, Jianhua ^a,c   Jia, Guang ^a,c   Zheng, Jolene ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b CATHOLIC UNIVERSITY OF PELOTAS   (Brazil)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Body composition; Cachexia; Nutritional assessment; Sarcopenia; Sarcopenic obesity

Indexed keywords

3 METHYLHISTIDINE; ACTIN; CREATININE; MYOSIN;

ANTHROPOMETRY; BIOIMPEDANCE ANALYSIS; BODY COMPOSITION; BODY FAT; BODY MASS; BODY SIZE; CACHEXIA; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; HUMAN; MORBIDITY; MORTALITY; MUSCLE FUNCTION; MUSCLE MASS; MUSCULOSKELETAL SYSTEM EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL ASSESSMENT; PRACTICE GUIDELINE; PROTEIN DEGRADATION; SARCOPENIA; SARCOPENIC OBESITY; SKELETAL MUSCLE; URINE LEVEL; WATER FAT IMAGING; COMPLICATION; DIAGNOSTIC IMAGING; FITNESS; MUSCLE STRENGTH; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

BODY COMPOSITION; DIAGNOSTIC IMAGING; HUMANS; MUSCLE STRENGTH; MUSCLE, SKELETAL; PHYSICAL FITNESS; SARCOPENIA;

EID: 84948123164     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665115000129     Document Type: Conference Paper

References (107)

1. Silva AM, Shen W, Heo M, et al. (2010). Ethnicity-related skeletal muscle differences across the lifespan. Am J Hum Biol. 22, 76-82.
2. Heymsfield SB, Adamek M, Gonzalez MC, et al. (2014). Assessing skeletal muscle mass: historical overview, and state of the art. J Cachexia Sarcopenia Muscle. 5, 9-18.
3. Heymsfield SB, Peterson CM, Thomas DM, et al. (2014). Scaling of adult body weight to height across sex, and race/ethnic groups: relevance to BMI. Am J Clin Nutr. 100, 1455-1461.
4. Thomas D, Das SK, Levine JA, et al. (2010). New fat free mass - fat mass model for use in physiological energy balance equations. Nutr Metab (Lond) 7, 39.
5. Heymsfield SB, Scherzer R, Pietrobelli A, et al. (2009). Body mass index as a phenotypic expression of adiposity: quantitative contribution of muscularity in a population-based sample. Int J Obes (Lond) 33, 1363-1373.
6. McNally EM. (2004). Powerful genes - myostatin regulation of human muscle mass. N Engl J Med. 350, 2642-2644.
7. Bhasin S, Cunningham GR, Hayes FJ, et al. (2010). Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 95, 2536-2559.
8. Houston DK, Nicklas BJ, Ding J, et al. (2008). Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr. 87, 150-155.
9. Janssen I, Heymsfield SB, Wang ZM, et al. (2000). Skeletal muscle mass, and distribution in 468 men, and women aged 18-88 yr. J Appl Physiol. 89, 81-88.
10. Forbes GB. (1999). Longitudinal changes in adult fat-free mass: influence of body weight. Am J Clin Nutr. 70, 1025-1031.
11. Gallagher D, Ruts E, Visser M, et al. (2000). Weight stability masks sarcopenia in elderly men, and women. Am J Physiol Endocrinol Metab. 279, E366-E375.
12. Alexandre Tda S, Duarte YA, Santos JL, et al. (2014). Sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) versus dynapenia as a risk factor for mortality in the elderly. J Nutr Health Aging. 18, 751-756.
13. McGregor RA, Cameron-Smith D, & Poppitt SD. (2014). It is not just muscle mass: a review of muscle quality, composition, and metabolism during ageing as determinants of muscle function, and mobility in later life. Longev Healthspan 3, 9.
14. Yamada Y, Schoeller DA, Nakamura E, et al. (2010). Extracellular water may mask actual muscle atrophy during aging. J Gerontol A Biol Sci Med Sci. 65, 510-516.
15. Filippin LI, Teixeira VN, da Silva MP, et al. (2014). Sarcopenia: a predictor of mortality, and the need for early diagnosis, and intervention. Aging Clin Exp Res (Epublication ahead of print version
16. Studenski SA, Peters KW, Alley DE, et al. (2014). The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 69, 547-558.
17. Lee RC, Wang ZM, & Heymsfield SB. (2001). Skeletal muscle mass, and aging: regional, and whole-body measurement methods. Can J Appl Physiol. 26, 102-122.
18. Kob R, Bollheimer LC, Bertsch T, et al. (2015). Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?. Biogerontology. 16, 15-29.
19. Johns N, Hatakeyama S, Stephens NA, et al. (2014). Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLoS ONE. 9, e83618.
20. Milte R, & Crotty M. (2014). Musculoskeletal health, frailty, and functional decline. Best Pract Res Clin Rheumatol. 28, 395-410.
21. Walston JD. (2012). Sarcopenia in older adults. Curr Opin Rheumatol. 24, 623-627.
22. Matiegka J. (1921). The testing of physical efficiency. Am J Phys Anthropol. 4, 223-230.
23. Martin AD, Spenst LF, Drinkwater DT, et al. (1990). Anthropometric estimation of muscle mass in men. Med Sci Sports Exerc. 22, 729-733.
24. Doupe MB, Martin AD, Searle MS, et al. (1997) A new formula for population-based estimation of whole body muscle mass in males. Can J Appl Physiol. 22, 598-608.
25. Hounsfield GN. (1973). Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol. 46, 1016-1022.
26. Al-Gindan YY, Hankey C, Govan L, et al. (2014). Derivation, and validation of simple equations to predict total muscle mass from simple anthropometric, and demographic data. Am J Clin Nutr. 100, 1041-1051.
27. Heymsfield SB. (1990). Anthropometric measurements: application in hospitalized patients. Infusionstherapie. 17, Suppl. 3, 48-51.
28. Heymsfield SB, McManus C, Smith J, et al. (1982). Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 36, 680-690.
29. Newman AB, Kupelian V, Visser M, et al. (2006). Strength, but not muscle mass, is associated with mortality in the health, aging, and body composition study cohort. J Gerontol A Biol Sci Med Sci. 61, 72-77.
30. Goodpaster BH, Park SW, Harris TB, et al. (2006). The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging, and body composition study. J Gerontol A Biol Sci Med Sci. 61, 1059-1064.
31. Chevreul E. (1835). Sur la composition chimique du bouillon de viandes (On the chemical composition of meatbroth). J Pharm Sci Access. 21, 231-242.
32. Heymsfield SB, Arteaga C, McManus C, et al. (1983). Measurement of muscle mass in humans: validity of the. 24-hour urinary creatinine method. Am J Clin Nutr. 37, 478-494.
33. Forbes GB, & Bruining GJ. (1976). Urinary creatinine excretion, and lean body mass. Am J Clin Nutr. 29, 1359-1366.
34. Wang ZM, Sun YG, & Heymsfield SB. (1996). Urinary creatinine-skeletal muscle mass method: a prediction equation based on computerized axial tomography. Biomed Environ Sci. 9, 185-190.
35. Clark BC, & Manini TM. (2010). Functional consequences of sarcopenia, and dynapenia in the elderly. Curr Opin Clin Nutr Metab Care. 13, 271-276.
36. Patel SS, Molnar MZ, Tayek JA, et al. (2013). Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study, and review of literature. J Cachexia, Sarcopenia Muscle 4, 19-29.
37. Lukaski HC, Mendez J, Buskirk ER, et al. (1981). Relationship between endogenous 3-methylhistidine excretion, and body composition. Am J Physiol. 240, E302-E307.
38. Dussik KT. (1954). The ultrasonic field as a medical tool. Am J Phys Med. 33, 5-20.
39. Ludwig GD, Bolt RH, Heuter TF, et al. (1950). Factors influencing the use of ultrasound as a diagnostic aid. Trans Am Neurol Assoc. 51, 225-228.
40. Pillen S, & van Alfen N. (2011). Skeletal muscle ultrasound. Neurol Res. 33, 1016-1024.
41. Smith-Ryan AE, Fultz SN, Melvin MN, et al. (2014). Reproducibility, and validity of A-mode ultrasound for body composition measurement, and classification in overweight, and obese men, and women. PLoS ONE. 9, e91750.
42. Dietz HP. (2004). Ultrasound imaging of the pelvic floor. Part II: three-dimensional or volume imaging. Ultrasound Obstet Gynecol. 23, 615-625.
43. Ikai M, & Fukunaga T. (1968). Calculation of muscle strength per unit cross-sectional area of human muscle by means of ultrasonic measurement. Int Z Angew Physiol. 26, 26-32.
44. Sanada K, Kearns CF, Midorikawa T, et al. (2006). Prediction, and validation of total, and regional skeletal muscle mass by ultrasound in Japanese adults. Eur J Appl Physiol. 96, 24-31.
45. Abe T, Loenneke JP, Young KC, et al. (2015). Validity of ultrasound prediction equations for total, and regional muscularity in middle-Aged, and older men, and women. Ultrasound Med Biol. 41, 557-564.
46. Loenneke JP, Thiebaud RS, & Abe T. (2014). Estimating site-specific muscle loss: a valuable tool for early sarcopenia detection?. Rejuvenation Res. 17, 496-498.
47. Drakonaki EE, Allen GM, & Wilson DJ. (2012). Ultrasound elastography for musculoskeletal applications. Br J Radiol. 85, 1435-1445.
48. Harris-Love MO, Monfaredi R, Ismail C, et al. (2014). Quantitative ultrasound: measurement considerations for the assessment of muscular dystrophy, and sarcopenia. Front Aging Neurosci 6, 172.
49. Pedersen M, Fredberg U, Langberg H, et al. (2012). Sonoelastography as a diagnostic tool in the assessment of musculoskeletal alterations: a systematic review. Ultraschall Med. 33, 441-446.
50. Watanabe Y, Yamada Y, Fukumoto Y, et al. (2013). Echo intensity obtained from ultrasonography images reflecting muscle strength in elderly men. Clin Interv Aging. 8, 993-998.
51. Hoffer EC, Meador CK, & Simpson DC. (1969). Correlation of whole-body impedance with total body water volume. J Appl Physiol. 27, 531-534.
52. Nyboer J. (1972). Workable volume, and flow concepts of bio-segments by electrical impedance plethysmography. TIT J Life Sci. 2, 1-13.
53. Thomasset A. (1962). Bioelectrical properties of tissue impedance measurements. Lyon Med. 94, 107-118.
54. Organ LW, Bradham GB, Gore DT, et al. (1994). Segmental bioelectrical impedance analysis: theory, and application of a new technique. J Appl Physiol. (1985). 77, 98-112.
55. Tan BHL, Birdsell LA, Martin L, et al. (2009). Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 15, 6973-6979.
56. Brown BH, Karatzas T, Nakielny R, et al. (1988). Determination of upper arm muscle, and fat areas using electrical impedance measurements. Clin Phys Physiol Meas. 9, 47-55.
57. Jolene Zheng BZ, Gao C, Watson JM, et al. (editors). (2014). Sarcopenic Obesity: Clinical Diagnostic Potential of 8- Electrode Multi-Segmental BIA. Obesity Week; Boston
58. Norman K, Stobaus N, Pirlich M, et al. (2012). Bioelectrical phase angle, and impedance vector analysis - clinical relevance, and applicability of impedance parameters. Clin Nutr. 31, 854-861.
59. Fukumoto Y, Ikezoe T, Yamada Y, et al. (2012). Skeletal muscle quality assessed from echo intensity is associated with muscle strength of middle-Aged, and elderly persons. Eur J Appl Physiol. 112, 1519-1525.
60. Basile C, Della-Morte D, Cacciatore F, et al. (2014). Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia. Exp Gerontol. 58, 43-46.
61. Slee A, Birch D, & Stokoe D. (2015). Bioelectrical impedance vector analysis, phase-Angle assessment, and relationship with malnutrition risk in a cohort of frail older hospital patients in the United Kingdom. Nutrition. 31, 132-137.
62. Sun Y. (2009). Muscle Function Analyzer. China Patent: CN 201370584.
63. Stuart HC, & Hill-Dwinell P. (1942). The growth of bone, muscle, and overlying tissues in children 6 to 10 years of age as revealed by studies of roentgenograms of the leg area. Monogr Soc Res Child Dev. 13, 195.
64. Wells PNT. (2005). Sir Godfrey Newbold Hounsfield KT CBE. 28 August 1919-12 August 2004: elected F.R.S. 1975. Biogr Memoirs Fellows R Soc. 51, 221-235.
65. Bulcke JA, Termote JL, Palmers Y, et al. (1979). Computed tomography of the human skeletal muscular system. Neuroradiology. 17, 127-136.
66. Haggmark T, Jansson E, & Svane B. (1978). Cross-sectional area of the thigh muscle in man measured by computed tomography. Scand J Clin Lab Invest. 38, 355-360.
67. Heymsfield SB, Olafson RP, Kutner MH, et al. (1979) A radiographic method of quantifying protein-calorie undernutrition. Am J Clin Nutr. 32, 693-702.
68. Tokunaga K, Matsuzawa Y, Ishikawa K, et al. (1983) A novel technique for the determination of body fat by computed tomography. Int J Obes 7, 437-445.
69. Sjöström S. (1984). Chefer och människor. 1 uppl ed Solna: SIPU
70. Macchia RJ, Termine JE, Buchen CD, et al. (2007). Damadian, M.D.: magnetic resonance imaging, and the controversy of the 2003 Nobel Prize in Physiology or Medicine. J Urol. 178, 3 Pt. 1, 783-785.
71. Mazess RB, Cameron JR, & Sorenson JA. (1970). Determining body composition by radiation absorption spectrometry. Nature. 228, 771-772.
72. Kelly TL, Slovik DM, Schoenfeld DA, et al. (1988). Quantitative digital radiography versus dual photon absorptiometry of the lumbar spine. J Clin Endocrinol Metab. 67, 839-844.
73. Gallagher D, Kuznia P, Heshka S, et al. (2005). Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr. 81, 903-910.
74. Addison O, Marcus RL, Lastayo PC, et al. (2014). Intermuscular fat: a review of the consequences, and causes. Int J Endocrinol 2014, 309570.
75. Heymsfield SB, & Noel R. (1981). Radiographic analysis of body composition by computerized axial tomography. Nutr Cancer. 17, 161-172.
76. Goodpaster BH, Thaete FL, Simoneau JA, et al. (1997). Subcutaneous abdominal fat, and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 46, 1579-1585.
77. Prado CM, Maia YL, Ormsbee M, et al. (2013). Assessment of nutritional status in cancer - The relationship between body composition, and pharmacokinetics. Anticancer Agents Med Chem. 13, 1197-1203.
78. Heymsfield SB, Smith R, Aulet M, et al. (1990). Appendicular skeletal muscle mass: measurement by dualphoton absorptiometry. Am J Clin Nutr. 52, 214-218.
79. Kim J, Wang Z, Heymsfield SB, et al. (2002). Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 76, 378-383.
80. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. (2010). Sarcopenia: European consensus on definition, and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 39, 412-423.
81. Stenholm S, Harris TB, Rantanen T, et al. (2008). Sarcopenic obesity: definition, cause, and consequences. Curr Opin Clin Nutr Metab Care. 11, 693-700.
82. Bley TA, Wieben O, Francois CJ, et al. (2010). Fat, and water magnetic resonance imaging. JMagn Reson Imaging. 31, 4-18.
83. Karlsson A, Rosander J, Romu T, et al. (2014). Automatic, and quantitative assessment of regional muscle volume by multi-Atlas segmentation using whole-body water-fat MRI. J Magn Reson Imaging (Epublication ahead of print version
84. Thomas MS, Newman D, Leinhard OD, et al. (2014). Test-retest reliability of automated whole body, and compartmental muscle volume measurements on a wide bore 3T MR system. Eur Radiol. 24, 2279-2291.
85. Quetelet L, Knox R, & Smibert T. (1842) A treatise on man, and the development of his faculties, tr. (under the superintendence of R Knox). [T Smibert, editor]. Edinburgh: William, and Robert Chambers
86. Van Itallie TB, Yang MU, Heymsfield SB, et al. (1990). Height-normalized indices of the body's fat-free mass, and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr. 52, 953-959.
87. Baumgartner RN, Koehler KM, Gallagher D, et al. (1998). Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 147, 755-763.
88. Schuna JM Jr, Peterson CM, Thomas DM, et al. (2014). Scaling of adult regional body mass, and body composition as a whole to height: relevance to body shape, and body mass index. Am J Hum Biol (Epublication ahead of print version
89. Siervo M, Prado CM, Mire E, et al. (2014). Body composition indices of a load-capacity model: gender-, and BMI-specific reference curves. Public Health Nutr. Available at http://dx.doi.org/10.1017/S1368980014001918.
90. Forbes GB. (1993). The companionship of lean, and fat. Basic Life Sci. 60, 1-14.
91. Rolland Y, Gallini A, Cristini C, et al. (2014). Body-composition predictors of mortality in women aged/=75 y: data from a large population-based cohort study with a 17-y follow-up. Am J Clin Nutr. 100, 1352-1360.
92. Cooper R, Kuh D, & Hardy R. (2010). Objectively measured physical capability levels, and mortality: systematic review, and meta-Analysis. BMJ. 341, c4467.
93. Guralnik JM. (1997). Assessment of physical performance, and disability in older persons. Muscle Nerve Suppl. 5, S14-S16.
94. American College of Sports Medicine. (2013). ACSM Guidelines for Exercise Testing, and Prescription. 9th edition. London: Lippincott, Williams, and Wilkins
95. Rosenberg IH. (1997). Sarcopenia: origins, and clinical relevance. J Nutr. 127, Suppl. 5, 990S-991S.
96. McLean RR, Shardell MD, Alley DE, et al. (2014). Criteria for clinically relevant weakness, and low lean mass, and their longitudinal association with incident mobility impairment, and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 69, 576-583.
97. Cawthon PM, Peters KW, Shardell MD, et al. (2014). Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 69, 567-575.
98. Dam TT, Peters KW, Fragala M, et al. (2014). An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 69, 584-590.
99. Lee RC HS, Shen W, & Wang ZM. (2003). Total-body, and regional skeletal muscle mass measurement methods: an overview. Int J Body Compos Res. 1, 93-102.
100. Wang Z, Deurenberg P, Matthews DE, et al. (1998). Urinary 3-methylhistidine excretion: association with total body skeletal muscle mass by computerized axial tomography. J Parenter Enteral Nutr. 22, 82-86.
101. Janssen I, Heymsfield SB, Baumgartner RN, et al. (2000). Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol. (1985). 89, 465-471.
102. Kim HK, Lindquist DM, Serai SD, et al. (2013). Magnetic resonance imaging of pediatric muscular disorders: recent advances, and clinical applications. Radiol Clin North Am. 51, 721-742.
103. Robson MD, & Bydder GM. (2006). Clinical ultrashort echo time imaging of bone, and other connective tissues. NMR Biomed. 19, 765-780.
104. Glaser KJ, Manduca A, & Ehman RL. (2012). Review of MR elastography applications, and recent developments. J Magn Reson Imaging. 36, 757-774.
105. Akki A, Yang H, Gupta A, et al. (2014). Skeletal muscle ATP kinetics are impaired in frail mice. Age (Dordr) 36, 21-30.
106. Heinicke K, Dimitrov IE, Romain N, et al. (2014). Reproducibility, and absolute quantification of muscle glycogen in patients with glycogen storage disease by 13C NMR spectroscopy at 7 Tesla. PLoS ONE 9, e108706.
107. Zaiss M, & Bachert P. (2013). Chemical exchange saturation transfer (CEST), and MR Z-spectroscopy in vivo: a review of theoretical approaches, and methods. Phys Med Biol. 58, R221-R269.